CROSSBETA BIOSCIENCES
Crossbeta Biosciences is a biotech company that has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized by the presence of misfolded proteins, such as Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. Crossbeta’s unique stable oligomers maintain their biopathological properties for the screening of oligomer-specific therapeutics and for the development of biomarker and diagnostic assays.
CROSSBETA BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.crossbeta.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Nginx Sitelinks Search Box Euro
Similar Organizations
Triton Biosciences
Triton Biosciences is a Biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.crossbeta.com Semrush global rank: 4.03 M Semrush visits lastest month: 3.05 K
- Host name: web.dds.nl
- IP address: 83.96.176.80
- Location: Rotterdam Netherlands
- Latitude: 51.9073
- Longitude: 4.437
- Timezone: Europe/Amsterdam
- Postal: 3029
More informations about "Crossbeta Biosciences"
Crossbeta Biosciences - Crunchbase Company Profile & Funding
Crossbeta Biosciences is a biotech company that has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized …See details»
Crossbeta Biosciences B.V. | LinkedIn
Crossbeta Biosciences B.V. | 447 followers on LinkedIn. "We aim to develop drugs for unmet needs, which transform hope into quality of life." Crossbeta Biosciences is a biotechnology …See details»
CrossBeta Biosciences - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for CrossBeta Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Crossbeta Biosciences - Products, Competitors, Financials, …
Crossbeta is a privately held company based in the Netherlands with a proprietary technology for efficient oligomer-based drug discovery, with applications in Alzheimer's, Parkinson's, ALS and …See details»
Crossbeta Biosciences - Craft
Crossbeta Biosciences has 5 employees across 2 locations. See insights on Crossbeta Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Crossbeta
Jun 1, 2016 Crossbeta to supply PerkinElmer stable oligomers for use as AlphaLISA® analytes February 22, 2015 – Utrecht, The Netherlands Crossbeta Biosciences today announced that …See details»
Crossbeta Biosciences - Contacts, Employees, Board Members, …
We're working on getting contact data for Crossbeta BiosciencesCrossbeta Biosciences is a biotech company.See details»
Crossbeta Biosciences - Tech Stack, Apps, Patents & Trademarks
Nov 10, 2024 Crossbeta Biosciences is actively using 20 technologies for its website, according to BuiltWith. These include Viewport Meta , IPhone / Mobile Compatible , and Euro.See details»
CrossBeta Biosciences BV - VentureRadar
Crossbeta Biosciences is a biotech company aimed at developing therapeutic applications of its crossbeta technology. ... Find out more about CrossBeta Biosciences BV, Biotechnology and …See details»
Crossbeta Biosciences BV: Drug pipelines, Patents, Clinical trials ...
Explore Crossbeta Biosciences BV with its drug pipeline, therapeutic area, technology platform, 2 news, and 3 literature.See details»
Syngle Therapeutics, a new biotech company focused on …
Dec 11, 2020 In the past few years, supported with a grant of The Michael J Fox Foundation, a non-profit US organization which is dedicated to finding a cure for Parkinson’s disease, …See details»
Probiodrug and Crossbeta Biosciences enter into a strategic
Jun 30, 2016 About Crossbeta Biosciences Crossbeta Biosciences is a biotech company with a proprietary technology for efficient oligomer-based drug discovery, with applications in …See details»
Crossbeta, Servier announce strategic CNS collaboration
Crossbeta Biosciences and Servier today announced their collaboration in several research projects involving the use of Crossbeta’s technology for generating stable oligomers. …See details»
AdAlta licenses Alzheimer’s disease-specific shark antibodies to ...
Crossbeta Biosciences is a biotech company with a proprietary technology for efficient oligomer-based drug discovery, with applications in Alzheimer’s, Parkinson’s, ALS and Huntington’s …See details»
ImmunoPrecise to acquire Crossbeta Research BV - Newswire
Dec 22, 2017 Crossbeta offers its proprietary technology for strategic collaborative partnerships aimed at developing new oligomer targets and related screening assays and for therapeutic …See details»
Crossbeta Biosciences, Good Biomarker Sciences and U-Protein …
Feb 8, 2012 Crossbeta Biosciences, a biotechnology company focused on the discovery and development of drug treatments for misfolded protein diseases and a lead program in …See details»
AdAlta collaborates with Crossbeta to find i-body for Alzheimer’s ...
Today, Crossbeta Biosciences and AdAlta announced that they have established a collaborative relationship in which AdAlta will deploy its i-body technology to develop oligomer-specific i …See details»
[P1–277]: CROSSBETA STABLE Aβ OLIGOMERS: …
Jul 1, 2017 Furthermore, Crossbeta oligomers demonstrate typical functionality of pathological Aβ species such as neurotoxicity, in vivo LTP depression and induction of inflammatory …See details»
Probiodrug and Crossbeta Biosciences Extend Their Strategic
Dec 5, 2017 About Crossbeta Biosciences Crossbeta Biosciences is a biotech company with a proprietary technology for efficient oligomer-based drug discovery, with applications in …See details»
Probiodrug And Crossbeta Biosciences Extend Their Strategic …
US consumers expect higher inflation and better economy, New York Fed says · December 9, 2024 · 8:10 AM PST · 36 min ago U.S. consumers were bracing last month for higher levels of …See details»